Computational vaccinology: an important strategy to discover new potential S. mansoni vaccine candidates
- PMID: 22013383
- PMCID: PMC3196198
- DOI: 10.1155/2011/503068
Computational vaccinology: an important strategy to discover new potential S. mansoni vaccine candidates
Abstract
The flatworm Schistosoma mansoni is a blood fluke parasite that causes schistosomiasis, a debilitating disease that occurs throughout the developing world. Current schistosomiasis control strategies are mainly based on chemotherapy, but many researchers believe that the best long-term strategy to control schistosomiasis is through immunization with an antischistosomiasis vaccine combined with drug treatment. Several papers on Schistosoma mansoni vaccine and drug development have been published in the past few years, representing an important field of study. The advent of technologies that allow large-scale studies of genes and proteins had a remarkable impact on the screening of new and potential vaccine candidates in schistosomiasis. In this postgenomic scenario, bioinformatic technologies have emerged as important tools to mine transcriptomic, genomic, and proteomic databases. These new perspectives are leading to a new round of rational vaccine development. Herein, we discuss different strategies to identify potential S. mansoni vaccine candidates using computational vaccinology.
Figures

Similar articles
-
Vaccination with enzymatically cleaved GPI-anchored proteins from Schistosoma mansoni induces protection against challenge infection.Clin Dev Immunol. 2012;2012:962538. doi: 10.1155/2012/962538. Epub 2012 Aug 15. Clin Dev Immunol. 2012. PMID: 22927873 Free PMC article.
-
Evaluation of the use of C-terminal part of the Schistosoma mansoni 200kDa tegumental protein in schistosomiasis diagnosis and vaccine formulation.Exp Parasitol. 2014 Apr;139:24-32. doi: 10.1016/j.exppara.2014.02.003. Epub 2014 Feb 18. Exp Parasitol. 2014. PMID: 24560833
-
Schistosoma mansoni SmKI-1 or Its C-Terminal Fragment Induces Partial Protection Against S. mansoni Infection in Mice.Front Immunol. 2018 Jul 30;9:1762. doi: 10.3389/fimmu.2018.01762. eCollection 2018. Front Immunol. 2018. PMID: 30105029 Free PMC article.
-
Recent advances in vaccine research against schistosomiasis in Brazil.Acta Trop. 2008 Nov-Dec;108(2-3):256-62. doi: 10.1016/j.actatropica.2008.05.023. Epub 2008 Jun 5. Acta Trop. 2008. PMID: 18577363 Review.
-
The biotechnology-value chain: development of Sm14 as a schistosomiasis vaccine.Acta Trop. 2008 Nov-Dec;108(2-3):263-6. doi: 10.1016/j.actatropica.2008.09.002. Epub 2008 Sep 11. Acta Trop. 2008. PMID: 18834847 Review.
Cited by
-
S. mansoni Trapping in Lungs Contributes to Resistance to Reinfection.Front Immunol. 2015 Apr 21;6:186. doi: 10.3389/fimmu.2015.00186. eCollection 2015. Front Immunol. 2015. PMID: 25954278 Free PMC article. Review.
-
Proteomic Analysis of the Schistosoma mansoni Miracidium.PLoS One. 2016 Jan 22;11(1):e0147247. doi: 10.1371/journal.pone.0147247. eCollection 2016. PLoS One. 2016. PMID: 26799066 Free PMC article.
-
DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection.PLoS One. 2015 May 5;10(5):e0125075. doi: 10.1371/journal.pone.0125075. eCollection 2015. PLoS One. 2015. PMID: 25942636 Free PMC article.
-
A Biomphalaria glabrata peptide that stimulates significant behaviour modifications in aquatic free-living Schistosoma mansoni miracidia.PLoS Negl Trop Dis. 2019 Jan 22;13(1):e0006948. doi: 10.1371/journal.pntd.0006948. eCollection 2019 Jan. PLoS Negl Trop Dis. 2019. PMID: 30668561 Free PMC article.
-
The omic approach to parasitic trematode research-a review of techniques and developments within the past 5 years.Parasitol Res. 2016 Jul;115(7):2523-43. doi: 10.1007/s00436-016-5079-1. Epub 2016 Apr 28. Parasitol Res. 2016. PMID: 27126082 Review.
References
-
- van der Werf MJ, de Vlas SJ, Brooker S, et al. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Tropica. 2003;86(2-3):125–139. - PubMed
-
- Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. The Lancet Infectious Diseases. 2006;6(7):411–425. - PubMed
-
- Harder A. Chemotherapeutic approaches to trematodes (except schistosomes) and cestodes: current level of knowledge and outlook. Parasitology Research. 2002;88(6):587–590. - PubMed
-
- Bergquist NR, Colley DG. Schistosomiasis vaccines: research to development. Parasitology Today. 1998;14(3):99–104. - PubMed
-
- Bergquist NR. Schistosomiasis: from risk assessment to control. Trends in Parasitology. 2002;18(7):309–314. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous